Related references
Note: Only part of the references are listed.Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: interobserver agreement and reproducibility across software platforms
Francesca Tutino et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial
Peter Borchmann et al.
LANCET ONCOLOGY (2021)
Liquid biopsy in Hodgkin lymphoma - moving beyond the proof of principle
Sven Borchmann
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Jasmin Mettler et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial
Anne-Segolene Cottereau et al.
BLOOD (2018)
Controversies in the Treatment of Classical Hodgkin Lymphoma
Dennis A. Eichenauer et al.
HEMASPHERE (2018)
Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation
Mani Akhtari et al.
BLOOD (2018)
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
Peter Borchmann et al.
LANCET (2017)
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
Michel Meignan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin's Lymphoma
John Radford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET
Thomas Carlier et al.
FRONTIERS IN MEDICINE (2015)
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients
Michel Meignan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
Salim Kanoun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Andrea Gallamini et al.
HAEMATOLOGICA (2014)
Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
John M. M. Raemaekers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma
Tae Min Kim et al.
CANCER (2013)
Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma
Moo-Kon Song et al.
CANCER SCIENCE (2013)
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Andreas Engert et al.
LANCET (2012)
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Andreas Engert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Report on the First International Workshop on interim-PET scan in lymphoma
Michel Meignan et al.
LEUKEMIA & LYMPHOMA (2009)
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe et al.
BLOOD (2008)
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease
Christophe Ferme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
State-of-the-art therapeutics: Hodgkin's lymphoma
JM Connors
JOURNAL OF CLINICAL ONCOLOGY (2005)
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
MR Weihrauch et al.
ANNALS OF HEMATOLOGY (2002)
Share Paper
